TY - JOUR T1 - Forbearance with endobronchial stenting: cognisance before conviction JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW DO - 10.1183/16000617.0189-2022 VL - 32 IS - 167 SP - 220189 AU - Sameer K. Avasarala AU - Hervé Dutau AU - Atul C. Mehta Y1 - 2023/03/31 UR - http://err.ersjournals.com/content/32/167/220189.abstract N2 - Endobronchial stenting is an important aspect of the practice of interventional pulmonology. The most common indication for stenting is the management of clinically significant airway stenosis. The list of endobronchial stents available on the market continues to grow. More recently, patient-specific 3D-printed airway stents have been approved for use. Airway stenting should be considered only when all other options have been exhausted. Due to the environment of the airways and the stent–airway wall interactions, stent-related complications are common. Although stents can be placed in various clinical scenarios, they should only be placed in scenarios with proven clinical benefit. The unwarranted placement of a stent can expose the patient to complications with little or no clinical benefit. This article reviews and outlines the key principles of endobronchial stenting and important clinical scenarios in which stenting should be avoided.Endobronchial stenting is a commonly performed procedure within interventional pulmonology and thoracic surgery. Several indications exist. Although useful, endobronchial stenting should be approached with prejudice in certain clinical conditions. https://bit.ly/3ZUtnqT ER -